CNXUNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends October 31
Conexeu Sciences Inc.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$3.29+0.23 (+7.52%)
Close on Oct 19, 2026
- Market cap
- $88.74M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.1%
0M of 28M shares
Institutional holders
8
8 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
3 buys · 0 sales
Net bought $838.00K
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund | 4,400,305 | 9.99% | 13G (passive) | May 21, 2026 |
| OnePointTwo Capital Performance LLC | 3,359,240 | 12.30% | 13G (passive) | Jun 30, 2026 |
| Wright Michael G. | 3,276,643 | 12.10% | 13G (passive) | Jun 30, 2026 |
| David Bogart | 2,293,750 | 8.10% | 13G (passive) | Jun 30, 2026 |
| OnePointTwo Capital Ventures LLC | 1,875,000 | 6.80% | 13G (passive) | Jun 30, 2026 |
| Paisley Capital Holdings Corp | 1,800,000 | 6.70% | 13G (passive) | Jun 30, 2026 |
| Jeffrey Sharpe | 1,500,000 | 5.20% | 13D (active) amendment | Sep 14, 2026 |
| OnePointTwo Capital Ventures II LLC | 1,484,240 | 5.50% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CNXU | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| UBS Group AG | 12,264 | 0.04% | $133.92K | New | 0.00% |
| Morgan Stanley | 5,871 | 0.02% | $64.11K | New | 0.00% |
| Citigroup Inc | 5,219 | 0.02% | $56.99K | New | 0.00% |
| Hollencrest Capital Management | 1,000 | 0.00% | $10.92K | New | 0.00% |
| Royal Bank of Canada | 887 | 0.00% | $10.00K | New | 0.00% |
| Integrated Wealth Concepts LLC | 400 | 0.00% | $4.37K | New | 0.00% |
| Osaic Holdings, Inc. | 100 | 0.00% | $1.09K | New | 0.00% |
| Jones Financial Companies Lllp | 100 | 0.00% | $1.10K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 8 | 0M | 0.1% | 8 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| David Robert Bogart | Chief Commercial Officer, Director | 2,243,750 | 7.95% | Sep 28, 2026 |
| Miles David Harrison | President and CEO, Director | 237,861 | 0.84% | May 11, 2026 |
| Claudia Itze Chavez-Munoz | Chief Science Officer | 444,111 | 1.57% | May 11, 2026 |
| Stephen Douglas Inouye | CFO, Secretary, and Treasurer | 57,525 | 0.20% | May 11, 2026 |
| Brian Keith Pilcher | Chief Medical Officer | 87,861 | 0.31% | May 11, 2026 |
| Jeffrey Nathan Sharpe | Director | 1,500,000 | 5.32% | Sep 15, 2026 |
| Lynn Sebastian Purcell | Director, 10% owner | 2,951,848 | 10.47% | Sep 9, 2026 |
| Andrew Costa | Director | – | – | Jun 29, 2026 |
| April Lynn Burke | Director | – | – | Jun 24, 2026 |
| Ana Lucia Bastiani-Posner | Director | – | – | Jun 23, 2026 |
| Zbigniew Paul Lorenc | Director | 433,323 | 1.54% | May 15, 2026 |
| Aaron Solomon Farberg | Director | 10,869 | 0.04% | May 11, 2026 |
| Michael G. Wright | 10% owner | 2,898,048 | 10.27% | Jun 22, 2026 |
| Capital Ventures LLC OnePointTwo | 10% owner | 1,047,500 | 3.71% | May 14, 2026 |
| Capital Ventures II LLC OnePointTwo | 10% owner | 1,484,240 | 5.26% | May 11, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| David Robert Bogart Chief Commercial Officer, Director | Sep 25, 2026 | Option exercise | +750,000 | – | – | 1,812,500 |
| Jeffrey Nathan Sharpe Director | Sep 14, 2026 | Option exercise | +500,000 | – | – | 1,500,000 |
| Lynn Sebastian Purcell Director, 10% owner | Sep 4, 2026 | Option exercise | +217,608 | $2.30 | $500.50K | 2,951,848 |
| Lynn Sebastian Purcell Director, 10% owner | Sep 4, 2026 | Option exercise | +217,608 | $2.30 | $500.50K | 2,951,848 |
| Lynn Sebastian Purcell Director, 10% owner | Jun 18, 2026 | Buy | +202,500 | $0.80 | $162.00K | 2,734,240 |
| Michael G. Wright 10% owner | Jun 18, 2026 | Option exercise | +250,000 | – | – | 2,148,048 |
| Michael G. Wright 10% owner | May 26, 2026 | Option exercise | +400,000 | – | – | 1,898,048 |
| Jeffrey Nathan Sharpe Director | May 22, 2026 | Option exercise | +500,000 | – | – | 1,000,000 |
| Zbigniew Paul Lorenc Director | May 14, 2026 | Award | +11,175 | – | – | 433,323 |
| Capital Ventures LLC OnePointTwo 10% owner | May 12, 2026 | Buy | +422,500 | $0.80 | $338.00K | 1,047,500 |
| Lynn Sebastian Purcell Director, 10% owner | May 12, 2026 | Buy | +422,500 | $0.80 | $338.00K | 2,531,740 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.